Vulnerabilities

Search by TI id or any alias (CVE, GHSA), vendor, product or CWE.

Filters

Reset all

Threatist priority CRITICAL 0 HIGH 0 MEDIUM 0 LOW 1

Signals Exploited in the wild (KEV) 0 Patch available 0 No fix listed 1 Has CVE 1

Fix status Fixed 0 Partial 0 Will not fix 0 Deferred 0 No fix listed 1

Impact type Code execution 0 Privilege escalation 0 Security bypass 1 Information disclosure 0 Tampering 0 Denial of service 0 Spoofing 0 Cross-site scripting 0 SQL injection 0

Attack vector Network 0 Adjacent network 1 Local 0 Physical 0

Requirements No authentication 1 No user interaction 1

Product

Products as named in CPE, with their records.

Published Last 7 days Last 30 days Last 12 months Any time

Weakness (CWE) CWE-284 Improper Access Control 1

1 selected

1 record

Sort

Vendor: Insulet × Clear all filters

TI-2020-08539 CVE-2020-10627 · GHSA-r26f-v6j2-2h4j

Improper access control in Insulet Omnipod Insulin Management System

Priority LOW 36

Insulet Omnipod Insulin Management System insulin pump product ID 19191 and 40160 is designed to communicate using a wireless RF with an Insulet manufactured Personal Diabetes Manager device.

CVSS 3.1HIGH 8.1· Adjacent network · No auth · No interaction · EPSS 0.00489 · Published 2021-12-01 · No fix listed CWE-284

THREATIST.IO

Vulnerability intelligence for security teams and AI agents.

Vulnerabilities Vendors Exploited (KEV) API & MCP Newsletter Privacy policy Terms of use

Newsletter Vulnerability intelligence in your inbox Subscribe

© 2026 Threatist.io · X (@threatist)Data: CVE Program, NVD, CISA KEV, FIRST EPSS, GitHub Advisory Database and Red Hat security data (both CC BY 4.0), Microsoft Security Response Center. This product uses the NVD API but is not endorsed or certified by the NVD. Sources and licences

We would like to use Google Analytics cookies to see how the site is used. They are set only if you accept. Privacy policy